Biological E applies for DCGI go-ahead to conduct phase-3 trial of Corbevax booster in people vaccinated with Covishield or Covaxin |
Journal Updates
eMediNexus Coverage from: 
Biological E applies for DCGI go-ahead to conduct phase-3 trial of Corbevax booster in people vaccinated with Covishield or Covaxin

0 Read Comments                

Biological E has asked the Drugs Controller General of India (DCGI) for permission to conduct phase-3 clinical trial of its vaccine against COVID-19, Corbevax, as a single booster dose for individuals who have received two doses of Covishield or Covaxin.Phase 2/3 clinical trials of Corbevax, an RBD protein sub-unit vaccine, for adults 18 to 80 years of age, are currently being done and the results will likely be announced this month. The company has now submitted an application to seek the ...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now